Pineal parenchymal tumours: II. On the aggressive behaviour of pineoblastoma in patients with an inherited mutation of the RB1 gene

Clinical Oncology

Volumn 16, Issue 4, 2004, Pages 244-247

  Plowman, P Nick ^a   Pizer, B ^b   Kingston, J E ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Pineal parenchymal tumours; Pineoblastoma; RBI gene

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; RETINOBLASTOMA PROTEIN; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; HUMAN; KAPLAN MEIER METHOD; PINEAL BODY TUMOR; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR CLASSIFICATION;

EID: 2542625139     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2003.12.005     Document Type: Article

References (16)

1. Gallie BL, Squire JA, Goddard A, et al. Mechanism of oncogenesis in retinoblastoma. Lab Investig 1990;62:394-408.
2. Knudson AG. Mutation and cancer: a statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
3. Onadim Z, Woolford AJ, Kingston JE, et al. The RB1 gene mutation in a child with ectopic intracranial retinoblastoma. Br J Cancer 1997;76:1405-1409.
4. Bader JL, Meadows AT, Zimmerman LE, et al. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: 'trilateral' retinoblastoma. Cancer Genet Cytogenet 1982;5:203-213.
5. Kingston JE, Plowman PN, Hungerford JL. Ectopic intracranial retinoblastoma in childhood. Br J Ophthalmol 1985;69:742-748.
6. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-442.
7. Pizer B, Taylor R, Weston C, et al. Analysis of patients with supratentorial PNET entered into the SIOP PNT 111 trial [abstract 0027]. Proc Soc Int Pediatr Oncol Sept 2002; Oporto.
8. Douek E, Plowman PN, Kingston JE. Platinum based chemotherapy for recurrent non-gliomatous brain tumours in young patients. J Neurol Neurosurg Psychiatr 1991;54:722-725.
9. Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing a shared chromosomal predisposition. Proc Natl Acad Sci USA 1985;82:6216-6223.
10. Harbour J, Lai SL, Whang Peng J, et al. Abnormalities in the structure and expression of the retinoblastoma genein SCLC. Science 1988;242:263-269.
11. Bookstein R, Lee EYHP, Peccei A, et al. Human retinoblastoma gene: long range mapping and analysis of its deletion in a breast cancer cell line. Mol Cell Biol 1989;9:1628-1635.
12. Stratton MR, Moss S, Warren W, et al. Mutation of the p53 gene in soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 1990;5:1297-1301.
13. Verhoog LC, Brekelmans CTM, Stratton MR, Seynaeve C, et al. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316-321.
14. Hafty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early onset breast cancer by BRCA1/2 status. Lancet 2002;359:1471-1477.
15. Dosaka-Akita H, Hu SX, Fujino M, et al. Altered retinoblastoma protein expression in non-small cell lung cancer: its synergistic effects with altered ras and p53 status on prognosis. Cancer 1997; 79:1329-1337.
16. Williams BO, Remington L, Albert DM, et al. Co-operative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994;7:480-484.